ResearcherMax Delbrück CenterActive in the last 2 years
Hazal Köse
Matched on ORCID iD 0000-0003-4307-5654; OpenAlex author ID A5013573948. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
- Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2025.08.018↗
- NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2105691119↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ulrich Bernd Keller · 3 shared papers, 2022–2026 · strength 0.52
- Paper Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancrea… DOI 10.1053/j.gastro.2025.08.018↗
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. DOI 10.1073/pnas.2105691119↗
- Günter Schneider · 3 shared papers, 2022–2026 · strength 0.52
- Paper Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancrea… DOI 10.1053/j.gastro.2025.08.018↗
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. DOI 10.1073/pnas.2105691119↗
- Matthias Wirth · 3 shared papers, 2022–2026 · strength 0.52
- Paper Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancrea… DOI 10.1053/j.gastro.2025.08.018↗
- Paper The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. DOI 10.1002/mco2.70794↗
- Paper NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. DOI 10.1073/pnas.2105691119↗
- Christian Schneeweis · 2 shared papers, 2026 · strength 0.40
- Michael B. Ghadimi · 2 shared papers, 2026 · strength 0.40
- Constanza Tapia Contreras · 2 shared papers, 2026 · strength 0.40
- Elisabeth Heßmann · 2 shared papers, 2026 · strength 0.40
- Dieter Saur · 2 shared papers, 2026 · strength 0.40
- Felix Orben · 2 shared papers, 2022–2026 · strength 0.31
- Maximilian Reichert · 2 shared papers, 2022–2026 · strength 0.31
- Oliver Holger Krämer · 2 shared papers, 2022–2026 · strength 0.31
- Marian Grade · 1 shared paper, 2026 · strength 0.19
- Lukas Krauß · 1 shared paper, 2026 · strength 0.19
- Carolin Schneider · 1 shared paper, 2026 · strength 0.19
- Roland Michael Schmid · 1 shared paper, 2026 · strength 0.19
- Janine Murr · 1 shared paper, 2026 · strength 0.19
- Alexandra Nguyen · 1 shared paper, 2026 · strength 0.19
- Sebastian Mueller · 1 shared paper, 2026 · strength 0.19
- Roland Rad · 1 shared paper, 2026 · strength 0.19
- Volker Ellenrieder · 1 shared paper, 2026 · strength 0.19
- Josefina Doffo · 1 shared paper, 2022 · strength 0.12
- Elmar Wolf · 1 shared paper, 2022 · strength 0.12
- Iréne Esposito · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.